Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-25-015480
Filing Date
2025-04-24
Accepted
2025-04-24 17:02:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20044252x2_defa14a.htm DEFA14A 11221
2 ny20044252x2_nc01.jpg GRAPHIC 311885
3 ny20044252x2_nc02.jpg GRAPHIC 285813
  Complete submission text file 0001140361-25-015480.txt   835397
Mailing Address 47 HULFISH STREET PRINCETON NJ 08542
Business Address 47 HULFISH STREET PRINCETON NJ 08542 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33497 | Film No.: 25868745
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)